This announcement confirms the completion of the obligatory share offer by Wang Qingtai and Cao Xiaobing for Tibet Doray Pharmaceutical Co., Ltd. The offer aimed to acquire 19,440,000 shares, representing 24.30% of the total share capital, at RMB 32.07 per share. The offer period concluded on February 24, 2026, with the acquirers successfully obtaining 19,440,000 shares.
Summary generated by AI · Always verify with source document
Securities Code: 301075 Securities Abbreviation: Doray Pharmaceutical Announcement No.: 2026-016
Tibet Doray Pharmaceutical Co., Ltd.
Announcement on the Completion of Transfer of Shares in the Company via Obligatory Offer by Wang Qingtai and Cao Xiaobing
The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, without any false records, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.